603676 Xizang Weixinkang Pharmaceutical
- 9.87
- -0.26-2.57%
Xizang Weixinkang Pharmaceutical News
Tibet Weixinkang Pharmaceutical Co., Ltd. Equity Distribution Implementation Notice for the First Three Quarters of 2024
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the progress of share repurchase
Announcement of the profit distribution plan for the first three quarters of 2024 of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the progress of share repurchase
Wei Xinkang: Announcement of the results of the directors and senior management of Tibet Weixinkang Pharmaceutical Co., Ltd. due to the end of the period of centralized bidding to reduce their holdings and the lack of implementation of holdings reduction
Announcement of the results of the directors and senior management of Tibet Weixinkang Pharmaceutical Co., Ltd. due to the expiration of the period of centralized bidding to reduce their holdings and the lack of implementation of holdings reduction
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the progress of share repurchase
Report of Tibet Weixinkang Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement of the implementation of equity distribution of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of the 2021 Restricted Stock Incentive Plan of Tibet Weixinkang Pharmaceutical Co., Ltd. for the first time and reservation grant for the second period of lifting sales restrictions and the cancellation of sales restrictions and listing
Announcement of the plan for directors and senior management of Tibet Weixinkang Pharmaceutical Co., Ltd. to reduce their shareholding through centralized bidding
Announcement on the 2023 Profit Distribution Plan of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement on the achievements of Tibet Weixinkang Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan for the first time and reservation grants part of the second period of lifting the sales restriction conditions
Legal opinion of the Shanghai Branch of Beijing Tianyuan Law Firm on matters relating to the lifting of sales restrictions in the 2021 Restricted Stock Incentive Plan of Tibet Weixinkang Pharmaceutical Co., Ltd. for the first time and reservation to grant some restricted shares in the second phase
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the release of the controlling shareholder\'s share pledge
Announcement on the results of shareholders holding more than 5% of the shares of Tibet Weixinkang Pharmaceutical Co., Ltd. reducing their shareholding
Tibet Weixinkang Pharmaceutical Co., Ltd. Equity Distribution Implementation Notice
Announcement of the 2022 profit distribution plan of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement on the progress of shareholder holdings of Tibet Weixinkang Pharmaceutical Co., Ltd. holding 5% or more of its holdings reduced by more than half of the time period and the progress of the share reduction
Announcement on the results of centralized bidding by senior management of Tibet Weixinkang Pharmaceutical Co., Ltd. to reduce stock holdings
Analysis
Price Target
No Data
No Data